Abstract:IMPORTANCE: Globally, treatment-resistant depression affects approximately one-third of all patients diagnosed with major depressive disorder. Currently, there are neither behavioral nor neural measures that quantitatively phenotype characteristics underlying treatment-resistant depression. OBJECTIVE: Determine whether neurocomputational models that integrate information about adaptive behavior and associated self-reported feelings can characterize differences in patients with treatment-resistant depression. DESIGN: In this observational study, data were collected over two research visits from 2020-2023 that occurred before and after standard-of-care electroconvulsive therapy (ECT) for treatment-resistant depression. This report focuses on Visit 1, which occurred after patients consented to ECT but before their initial treatment. SETTING: Wake Forest University School of Medicine; Atrium Health Wake Forest Baptist Psychiatric Outpatient Center; Atrium Health Wake Forest Hospital. PARTICIPANTS: Participants planning to receive ECT for depression (pre-ECT) and participants not planning to receive ECT with (non-ECT) or without depression (no-depression), were recruited from the Psychiatric Outpatient Center and community. EXPOSURES: Computerized delivery of a Probabilistic Reward and Punishment with Subjective Rating task during fMRI. MAIN OUTCOMES AND MEASURES: Computational modeling of choice behavior provided parameters that characterized learning dynamics and associated affect dynamics expressed through intermittent Likert scale self-reports. Multivariate statistical analyses relating model parameters, neurobehavioral responses, and clinical assessments. RESULTS: Pre-ECT (N=29; 55.2% female), non-ECT (N=40; 70% female), and no-depression (N=41; 65.9% female). Parameters derived from computational models fit to behavior elicited during learning and the expression of affective experiences clearly differentiates the three groups. Reinforcement Learning model parameters alone do not perform as well as models that incorporate affective self-reports. Notably, the set of model parameters that include learning and affective dynamics demonstrated excellent, cross-validated, diagnostic classification of depression diagnosis. Prior to ECT, neurobehavioral responses associated with learning and affective experiences about "punishing" events were significantly impaired in pre-ECT compared to non-ECT and no-depression cohorts. CONCLUSIONS AND RELEVANCE: Computational models of behavioral dynamics associated with learning and affect can describe specific hypotheses about neurocomputational-mechanisms underlying treatment-resistant depression. The present work suggests differences in processing of emotionally negative states and suggests a potential model-based behavioral diagnostic for individuals with major depression. Such models may eventually be used to augment the diagnosis of treatment-resistant depression or possibly determine phenotype-genotype relationships for disease status and progression.

Computational Psychopharmacology: a Translational and Pragmatic Approach

Cross‐species Studies of Cognition Relevant to Drug Discovery: a Translational Approach

Translating Cognition from Animals to Humans

From Computation to Clinic

Computational approaches to treatment response prediction in major depression using brain activity and behavioral data: A systematic review

Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics

Predicting treatment outcome in depression: an introduction into current concepts and challenges

Quantitative systems pharmacology in neuroscience: Novel methodologies and technologies

Translational Approaches to Frontostriatal Dysfunction in Attention-Deficit/Hyperactivity Disorder Using A Computerized Neuropsychological Battery

Chemical Neuromodulation of Frontal-Executive Functions in Humans and Other Animals

Neuropharmacological Modulation of Cognition

Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders

Thinking computationally in translational psychiatry. A commentary on Neville et al. (2024)

Computational Mechanism for the Effect of Psychosis Community Treatment: A Conceptual Review From Neurobiology to Social Interaction

Computational Phenotyping of Treatment-Resistant Depression prior to Electroconvulsive Therapy

Use of quantitative clinical pharmacology to improve early clinical development success in neurodegenerative diseases

Neural effects of dopaminergic compounds revealed by multi-site electrophysiology and interpretable machine-learning

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants

Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options

The future of rodent models in depression research

Optogenetic and chemogenetic insights into the neurocircuitry of depression‐like behaviour: A systematic review